StockData
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. (BIAF) stock

BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$1.93−0.07 (-3.50%)

Close on Nov 17, 2026Market cap $15.64MP/E –Yield –

bioAffinity Technologies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

bioAffinity Technologies's enterprise value was -$1.30M on Nov 11, 2026, against -$2.17M a year earlier. Over the last 4 years it ranged from -$3.41M to $25.50M, with a median of $5.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.30M–
2025Dec 31, 2025-$3.28M-128.2%
2024Dec 31, 2024$11.61M+28.4%
2023Dec 29, 2023$9.04M–
2022Dec 30, 2022-$105.99K–

More bioAffinity Technologies figures

See a number that looks wrong?